Key result
Targeting 12-lipoxygenase and its metabolites may offer a novel approach for anti-platelet therapies to attenuate clot formation and vessel occlusion.
Design
Review
Authors
Loading...
Should not yet change antiplatelet practice; leaves open therapeutic potential of 12-lipoxygenase targeting pending clinical trials.
Targeting 12-lipoxygenase may offer a novel approach to anti-platelet therapy with potentially lower bleeding risks compared to existing treatments.
Yeung et al. (2011) conducted a review in Thrombosis and hemostasis. 12-lipoxygenase targeted therapies was evaluated. Targeting 12-lipoxygenase and its metabolites may offer a novel approach for anti-platelet therapies to attenuate clot formation and vessel occlusion.